Holen Sie sich die Stockscreener-App
10.94
0.27%
0.03
Vorhandelsmarkt:
11.00
0.06
+0.55%
Schlusskurs vom Vortag:
$10.91
Offen:
$10.87
24-Stunden-Volumen:
2.97M
Relative Volume:
0.47
Marktkapitalisierung:
$7.81B
Einnahmen:
$125.68M
Nettoeinkommen (Verlust:
$4.81B
KGV:
1.9363
EPS:
5.65
Netto-Cashflow:
$-781.21M
1W Leistung:
+1.67%
1M Leistung:
+4.99%
6M Leistung:
-12.69%
1J Leistung:
-3.10%
1-Tages-Spanne:
$10.84
$10.98
1-Wochen-Bereich:
$10.58
$11.06
52-Wochen-Spanne:
$8.73
$13.05
Roivant Sciences Ltd Stock (ROIV) Company Profile
Firmenname
Roivant Sciences Ltd
Sektor
Branche
Telefon
441-295-5950
Adresse
CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM11
Vergleichen Sie ROIV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ROIV
Roivant Sciences Ltd
|
10.94 | 7.68B | 125.68M | 4.81B | -781.21M | 5.65 |
|
ONC
Beigene Ltd Adr
|
238.76 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.03 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2548 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
596.85 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
72.69 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-01-05 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-17 | Eingeleitet | Guggenheim | Buy |
| 2023-06-08 | Eingeleitet | BofA Securities | Neutral |
| 2022-10-27 | Eingeleitet | JP Morgan | Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Outperform |
| 2022-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-12-15 | Eingeleitet | Goldman | Buy |
| 2021-11-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-28 | Eingeleitet | Citigroup | Buy |
| 2021-10-26 | Eingeleitet | Cowen | Outperform |
| 2021-10-26 | Eingeleitet | Jefferies | Buy |
| 2021-10-26 | Eingeleitet | Truist | Buy |
Alle ansehen
Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten
Roivant Sciences (ROIV) Projected to Post Quarterly Earnings on Thursday - Defense World
IMVT INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into a Private Placement Transaction by Immunovant, Inc. and Encourages Investors to Contact the Firm - FinancialContent
Bank of America Corp DE Cuts Stake in Roivant Sciences Ltd. (NASDAQ:ROIV) - Defense World
Don't Ignore The Insider Selling In Roivant Sciences - simplywall.st
Dimensional Fund Advisors LP Sells 71,627 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - Defense World
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025 and Provide Business Update on Thursday, May 29, 2025 - Yahoo Finance
Transcript : Immunovant, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 04 - marketscreener.com
Roivant Sciences at BofA Securities: Strategic Shifts and Litigation Focus By Investing.com - Investing.com India
Transcript : Roivant Sciences Ltd. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 04 - marketscreener.com
Roivant Sciences at BofA Securities: Strategic Shifts and Litigation Focus - Investing.com Australia
How To Trade (ROIV) - news.stocktradersdaily.com
Wells Fargo & Company MN Boosts Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - Defense World
Envestnet Asset Management Inc. Makes New Investment in Roivant Sciences Ltd. (NASDAQ:ROIV) - Defense World
(ROIV) On The My Stocks Page - news.stocktradersdaily.com
Roivant Sciences Ltd. (ROIV): Among David Einhorn’s Stock Picks with Huge Upside Potential - Yahoo Finance
Roivant Sciences Ltd. (ROIV): Among Billionaire Andreas Halvorsen’s Stock Picks With Huge Upside Potential - Insider Monkey
Russell Investments Group Ltd. Buys 1,948 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - Defense World
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update - ADVFN
Roivant Sciences: Primed For Growth With A De-Risked Pipeline (NASDAQ:ROIV) - Seeking Alpha
Roivant sciences president Eric Venker sells $1.02 million in stock By Investing.com - Investing.com India
Roivant sciences president Eric Venker sells $1.02 million in stock - Investing.com
Roivant Sciences stock holds $18 target, management shuffle - Investing.com Australia
Roivant Sciences stock holds $18 target, management shuffle By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains overweight on Roivant Sciences stock - Investing.com Australia
Immunovant makes leadership changes - MSN
Roivant Tightens Leadership Grip On Immunovant, Narrows Near-Term IMVT-1402 Focus - insights.citeline.com
Cantor Fitzgerald maintains overweight on Roivant Sciences stock By Investing.com - Investing.com South Africa
Immunovant, Inc. Announces the Expanded Development of Imvt-1402 into Two New Indications, Sjd and Cle - marketscreener.com
Immunovant Announces Next Phase Of Growth With Roivant Including Changes To Its Leadership Team And Additional Indications - marketscreener.com
When (ROIV) Moves Investors should Listen - news.stocktradersdaily.com
Is Roivant Sciences Ltd. (ROIV) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? - Yahoo Finance
Roivant Sciences Ltd. (ROIV): Among the Best Low Priced Growth Stocks to Invest In - Insider Monkey
ROIV Factor-Based Stock Analysis - Nasdaq
Immunovant, Roivant slip after trial data for autoimmune disorder therapy - MSN
Knott David M Jr Decreases Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
KLP Kapitalforvaltning AS Invests $918,000 in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
ROIV stock touches 52-week low at $9.96 amid market fluctuations By Investing.com - Investing.com South Africa
ROIV stock touches 52-week low at $9.96 amid market fluctuations - Investing.com Australia
Is Roivant Sciences (ROIV) the Best Mid Cap Biotech Stock to Buy? - Insider Monkey
Loomis Sayles & Co. L P Has $43.43 Million Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells 315,522 Shares of Stock - MarketBeat
Is Roivant Sciences Ltd. (NASDAQ:ROIV) One of The Best Stocks to Buy According to Billionaire David Einhorn? - Insider Monkey
Roivant Sciences president Eric Venker sells shares worth $8.19 million By Investing.com - Investing.com UK
Roivant Sciences president Eric Venker sells shares worth $8.19 million - Investing.com
(ROIV) Trading Advice - news.stocktradersdaily.com
Roivant Sciences finalizes consulting agreement with former officer - Investing.com India
Finanzdaten der Roivant Sciences Ltd-Aktie (ROIV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
6.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):